QS heads into its October 21 earnings date with the stock down 18% over the past month, short sellers deeply entrenched, and options traders positioned more bullishly than usual despite the selloff.
The short interest picture is the defining feature of this stock right now. Bears hold nearly 99.4 million shares short, equal to 17.7% of the free float, a level that has barely budged in a month. The week-on-week change is less than 1%, and the 30-day move is essentially flat, meaning conviction on the short side has been steady rather than escalating. The ORTEX short score has crept up to 73.7, its highest point of the past two weeks, as the stock continued to slide. Borrow remains cheap at under 1% annually, and the lending pool is far from squeezed: availability runs at 33.8%, well above the 52-week low of 26.9% touched last Thursday. That brief tightening on September 25, when availability dipped to its annual trough, eased quickly, and the borrow market has since loosened again. The setup is one of persistent, settled short positioning rather than anything that looks like an imminent squeeze.
Options traders tell the opposite story. The put/call ratio is running at 0.28, near the bottom of its 52-week range of 0.25 to 0.43, and roughly 0.8 standard deviations below its 20-day average. Call volume is dominating the options market, suggesting some participants are reaching for upside rather than hedging downside. That contrast with the short book is notable: shorts are dug in, but the derivatives market leans speculative and bullish.
The Street has gone quiet since the last earnings print. TD Cowen cut its target from $8 to $6 in late July, the most recent analyst action on record, maintaining a Hold. With the stock now at $4.59, the mean price target across covering analysts is $6.66, implying a gap of roughly 45%. The February actions from Evercore, HSBC and Morgan Stanley, all of which lowered targets to the $8 to $10 range, look stale against the current price. Factor scores reinforce the cautious tone: the short score ranks in the 5th percentile of all stocks in the ORTEX universe, and forward earnings momentum scores in the bottom quarter. QuantumScape is still pre-revenue, still burning cash, and the valuation multiples reflect that: price-to-book is 3.0x, declining sharply over the past 30 days alongside the stock.
One item on the ownership register is worth flagging. A Schedule 13D/A filed in March 2025 lists Jagdeep Singh, a co-founder, with 4.6% of shares outstanding. A 13D filing signals activist or engaged intent rather than passive ownership. However, as last disclosed, this stake was already below the 5% reporting threshold, and under SEC rules a holder dropping below 5% need not file again. Singh's current position and intentions are unknown. Separately, Porsche Automobil Holding remains the largest institutional holder by a wide margin at 13.9% of shares, unchanged since at least March. BlackRock added 6.75 million shares as recently as August 31, bringing its stake to 4.6%. Those two data points, a large strategic anchor and a recent institutional addition, sit awkwardly alongside 17.7% short interest and a stock at multi-year lows.
Insider activity is mechanical rather than meaningful. CTO Timothy Holme has been running a series of option exercises and same-day sales under a pre-arranged 10b5-1 plan, most recently selling 120,000 shares in mid-September at around $5.09. Pre-planned sales carry little informational weight as signals of insider conviction.
Earnings history sharpens the risk picture. The July 22 print sent the stock down 15.5% on the day and 18% over the following five trading sessions. Close peer SLDP fell 8.8% on the week while WRD dropped 11.1%, suggesting the broader group of pre-commercial battery technology names has been under sustained pressure. With the next print due October 21, the central question is less about any single quarter's numbers and more about whether the company can offer any tangible milestone on its path to commercial production.
See the live data behind this article on ORTEX.
Open QS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
